Stocksigma LogoStocksigma Logo

Chandan Healthcare Releases H1 FY27 Investor Presentation Following Robust Operational Expansion

Chandan Healthcare released its H1 FY27 investor presentation, reporting standalone Q2 FY27 revenue growth of 45.04% YoY to Rs 57.94 Cr, while EBITDA grew

Chandan Healthcare Releases H1 FY27 Investor Presentation Following Robust Operational Expansion

Chandan Healthcare Ltd 路 Investor Presentation 路 18 Nov 2026, 12:47 am

Chandan Healthcare Releases H1 FY27 Investor Presentation Following Robust Operational Expansion Chandan Healthcare released its H1 FY27 investor presentation, reporting standalone Q2 FY27 revenue growth of 45.04% YoY to Rs 57.94 Cr, while EBITDA grew 54.79% YoY to Rs 22.12 Cr with margins at 37.26%. PAT surged 224.19% YoY to Rs 18.61 Cr, aided by an exceptional gain of Rs 10.23 Cr net of tax from divesting its 53.56% stake in Chandan Pharmacy for Rs 16.77 Cr. The company expanded its franchise network to 685 centres as of 30th Sep'26, targeting 1,000 by FY27-end.

Original exchange filing (PDF)

More announcements from Chandan Healthcare Ltd

All Chandan Healthcare Ltd announcements